21. Phase I Study of Alternate‐Day Administration of S‐1, Oral Leucovorin, and Bevacizumab for Refractory Metastatic Colorectal Cancer. (17th June 2020) Authors: Masuishi, Toshiki; Taniguchi, Hiroya; Komori, Azusa; Mitani, Seiichiro; Narita, Yukiya; Kadowaki, Shigenori; Ura, Takashi; Ando, Masashi; Muro, Kei Journal: Oncologist Issue: Volume 25:Number 11(2020) Page Start: e1614 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Practical considerations in the use of regorafenib in metastatic colorectal cancer. (October 2020) Authors: Loupakis, Fotios; Antonuzzo, Lorenzo; Bachet, Jean-Baptiste; Kuan, Feng-Che; Macarulla, Teresa; Pietrantonio, Filippo; Xu, Rui-Hua; Taniguchi, Hiroya; Winder, Thomas; Yuki, Satoshi; Zeng, Shan; Bekaii-Saab, Tanios Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Prevention and management of cetuximab-related hypomagnesemia. Issue 28 (1st October 2022) Authors: Tejpar, Sabine; Taniguchi, Hiroya; Falco, Agustín; Velthuis, Erica; Valencia Pineda, Christian; Mesia, Ricard Journal: Journal of clinical oncology Issue: Volume 40:Issue 28(2022)Supplement Page Start: 321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study. (11th September 2017) Authors: Moriwaki, Toshikazu; Fukuoka, Shota; Taniguchi, Hiroya; Takashima, Atsuo; Kumekawa, Yusuke; Kajiwara, Takeshi; Yamazaki, Kentaro; Esaki, Taito; Makiyama, Chinatsu; Denda, Tadamichi; Satake, Hironaga; Suto, Takeshi; Sugimoto, Naotoshi; Enomoto, Masanobu; Ishikawa, Toshiaki; Kashiwada, Tomomi; Sugi... Journal: Oncologist Issue: Volume 23:Number 1(2018) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G). (August 2020) Authors: Sakai, Daisuke; Taniguchi, Hiroya; Sugimoto, Naotoshi; Tamura, Takao; Nishina, Tomohiro; Hara, Hiroki; Esaki, Taito; Denda, Tadamichi; Sakamoto, Takeshi; Okuda, Hiroyuki; Satoh, Taroh; Tsushima, Takahiro; Makiyama, Akitaka; Tsuda, Takashi; Hosokawa, Ayumu; Kuramochi, Hidekazu; Tokunaga, Shinya; M... Journal: European journal of cancer Issue: Volume 135(2020) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Randomised phase II trial of capecitabine plus oxaliplatin with continuous versus intermittent use of oxaliplatin as adjuvant chemotherapy for stage II/III colon cancer (CCOG-1302 study). (February 2021) Authors: Nakayama, Goro; Takano, Nao; Taniguchi, Hiroya; Ishigure, Kiyoshi; Yokoyama, Hiroyuki; Teramoto, Hitoshi; Hashimoto, Ryoji; Sakai, Mitsuru; Ishiyama, Akiharu; Kinoshita, Takashi; Hayashi, Naomi; Nakamura, Masanori; Hattori, Norifumi; Sato, Yusuke; Umeda, Shinichi; Uehara, Kei; Aiba, Toshisada; So... Journal: European journal of cancer Issue: Volume 144(2021) Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. Rationale and design of the BRAVERY study (EPOC1701): a multicentre phase II study of eribulin in patients with BRAF V600E mutant metastatic colorectal cancer. Issue 6 (13th November 2019) Authors: Masuishi, Toshiki; Taniguchi, Hiroya; Kotani, Daisuke; Bando, Hideaki; Komatsu, Yoshito; Shinozaki, Eiji; Nakajima, Takako Eguchi; Satoh, Taroh; Nishina, Tomohiro; Esaki, Taito; Wakabayashi, Masashi; Nomura, Shogo; Takahashi, Koji; Ono, Hiromi; Hirano, Nami; Fujishiro, Noriko; Fuse, Nozomu; Sato,... Journal: ESMO open Issue: Volume 4:Issue 6(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Real‐world data on microsatellite instability status in various unresectable or metastatic solid tumors. Issue 3 (7th February 2021) Authors: Akagi, Kiwamu; Oki, Eiji; Taniguchi, Hiroya; Nakatani, Kaname; Aoki, Daisuke; Kuwata, Takeshi; Yoshino, Takayuki Journal: Cancer science Issue: Volume 112:Issue 3(2021) Page Start: 1105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. Recommendations related to the analytical equivalence assessment of gene panel testing. Issue 10 (19th August 2022) Authors: Nagai, Sumimasa; Nishihara, Hiroshi; Suzuki, Takayoshi; Nishio, Kazuto; Taniguchi, Hiroya; Tsuchihara, Katsuya; Nakamura, Kohei; Takamatsu, Reika; Ueno, Toshihide; Aburatani, Hiroyuki; Kohno, Takashi; Kohsaka, Shinji Journal: Cancer science Issue: Volume 113:Issue 10(2022) Page Start: 3282 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. SCRUM‐Japan GI‐SCREEN and MONSTAR‐SCREEN: Path to the realization of biomarker‐guided precision oncology in advanced solid tumors. Issue 11 (16th September 2021) Authors: Nakamura, Yoshiaki; Fujisawa, Takao; Taniguchi, Hiroya; Bando, Hideaki; Okamoto, Wataru; Tsuchihara, Katsuya; Yoshino, Takayuki; Ohtsu, Atsushi Journal: Cancer science Issue: Volume 112:Issue 11(2021) Page Start: 4425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗